HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Alberto Bardelli Selected Research
Alberto Bardelli Research Topics
Disease
145
Neoplasms (Cancer)
03/2024 - 11/2003
112
Colorectal Neoplasms (Colorectal Cancer)
04/2024 - 08/2002
15
Neoplasm Metastasis (Metastasis)
01/2022 - 11/2003
14
Disease Progression
01/2021 - 07/2009
8
Breast Neoplasms (Breast Cancer)
01/2021 - 11/2004
7
Colonic Neoplasms (Colon Cancer)
01/2019 - 11/2004
6
Melanoma (Melanoma, Malignant)
01/2023 - 08/2009
5
Sarcoma (Soft Tissue Sarcoma)
01/2022 - 02/2014
5
Lung Neoplasms (Lung Cancer)
01/2021 - 09/2014
4
Carcinogenesis
01/2024 - 05/2004
4
Circulating Neoplastic Cells
08/2020 - 02/2014
4
Residual Neoplasm
09/2017 - 01/2008
4
Glioblastoma (Glioblastoma Multiforme)
09/2014 - 01/2009
3
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
03/2024 - 01/2019
3
Microsatellite Instability
01/2021 - 04/2010
3
Pancreatic Neoplasms (Pancreatic Cancer)
08/2017 - 10/2011
3
Adenocarcinoma
12/2016 - 08/2009
3
Carcinoma (Carcinomatosis)
11/2010 - 07/2009
2
Mucinous Adenocarcinoma (Mucinous Carcinoma)
01/2023 - 01/2017
2
Gastrointestinal Neoplasms (Gastrointestinal Cancer)
01/2019 - 01/2017
2
Cholangiocarcinoma
01/2019 - 01/2017
2
Hypoxia (Hypoxemia)
02/2012 - 07/2009
2
Stomach Neoplasms (Stomach Cancer)
04/2010 - 05/2004
Drug/Important Bio-Agent (IBA)
29
Cetuximab (Erbitux)
FDA Link
03/2020 - 05/2005
28
ErbB Receptors (EGF Receptor)
IBA
04/2024 - 05/2005
23
Monoclonal Antibodies
IBA
01/2023 - 05/2005
23
Panitumumab (Vectibix)
FDA Link
01/2022 - 05/2005
22
DNA (Deoxyribonucleic Acid)
IBA
01/2024 - 08/2002
20
Biomarkers (Surrogate Marker)
IBA
05/2023 - 10/2009
16
Proteins (Proteins, Gene)
FDA Link
02/2024 - 11/2004
15
Phosphotransferases (Kinase)
IBA
01/2021 - 05/2004
13
Circulating Tumor DNA
IBA
04/2024 - 02/2014
12
Cell-Free Nucleic Acids
IBA
05/2023 - 08/2013
11
Antibodies
IBA
06/2023 - 08/2010
10
Calcibiotic Root Canal Sealer
IBA
01/2023 - 11/2003
10
Immune Checkpoint Inhibitors
IBA
01/2023 - 12/2018
8
Mitogen-Activated Protein Kinase Kinases (MEKs)
IBA
01/2018 - 05/2012
6
Phosphoric Monoester Hydrolases (Phosphatases)
IBA
09/2015 - 11/2003
5
RNA (Ribonucleic Acid)
IBA
03/2024 - 01/2021
5
Oxaliplatin (Eloxatin)
FDA Link
Generic
02/2022 - 12/2016
4
Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)
IBA
02/2024 - 08/2005
4
Small Interfering RNA (siRNA)
IBA
02/2022 - 04/2014
4
olaparib
IBA
01/2022 - 10/2018
4
Temozolomide (Temodar)
FDA Link
Generic
01/2022 - 01/2017
4
Tyrosine (L-Tyrosine)
FDA Link
09/2010 - 05/2003
3
Antigens
IBA
03/2024 - 11/2018
3
pevonedistat
IBA
01/2023 - 01/2017
3
Trabectedin
IBA
01/2022 - 10/2018
3
Messenger RNA (mRNA)
IBA
01/2021 - 11/2003
3
Lapatinib (GW572016)
FDA Link
12/2020 - 06/2016
3
Trastuzumab (Herceptin)
FDA Link
12/2020 - 06/2016
3
Fluorouracil (Carac)
FDA Link
Generic
01/2020 - 03/2004
3
Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)
IBA
01/2020 - 04/2014
3
Adenosine Triphosphate (ATP)
IBA
01/2019 - 07/2007
3
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
08/2017 - 12/2010
3
Codon (Codons)
IBA
06/2016 - 10/2010
2
Forkhead Transcription Factors (Forkhead Box Proteins)
IBA
02/2024 - 01/2021
2
carfilzomib
IBA
02/2024 - 12/2013
2
Peptides (Polypeptides)
IBA
01/2024 - 01/2008
2
Irinotecan (Camptosar)
FDA Link
Generic
01/2024 - 12/2016
2
Proteasome Inhibitors
IBA
01/2023 - 12/2013
2
Proteasome Endopeptidase Complex (Proteasome)
IBA
01/2023 - 12/2013
2
Heme (Haem)
IBA
02/2022 - 01/2021
2
Alkylating Agents
IBA
12/2021 - 01/2017
2
Apoptosis Regulatory Proteins
IBA
01/2021 - 01/2017
2
Oxygen (Dioxygen)
IBA
01/2021 - 07/2009
2
Chromatin
IBA
01/2021 - 04/2014
2
pertuzumab
IBA
12/2020 - 01/2020
2
MicroRNAs (MicroRNA)
IBA
08/2020 - 02/2014
2
Ascorbic Acid (Vitamin C)
FDA Link
Generic
03/2020 - 01/2020
2
Poly(ADP-ribose) Polymerase Inhibitors
IBA
01/2020 - 01/2019
2
infigratinib
IBA
01/2019 - 01/2017
2
regorafenib
IBA
01/2019 - 12/2016
2
Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)
IBA
01/2019 - 01/2017
2
futuximab
IBA
04/2018 - 01/2016
2
Growth Factor Receptors
IBA
01/2018 - 05/2005
2
Transcription Factors (Transcription Factor)
IBA
08/2017 - 11/2004
2
Hepatocyte Growth Factor (Growth Factor, Hepatocyte)
IBA
01/2017 - 05/2013
2
Gemcitabine
FDA Link
12/2016 - 11/2010
2
Angiopoietin-2
IBA
12/2016 - 02/2015
2
Vemurafenib
IBA
01/2016 - 01/2012
2
entrectinib
IBA
01/2016 - 01/2016
2
PLX 4720
IBA
12/2013 - 02/2012
2
Protein Kinases (Protein Kinase)
IBA
03/2013 - 09/2010
2
Oncogene Proteins (Oncogene Protein)
IBA
01/2012 - 11/2011
2
Mitogen-Activated Protein Kinases
IBA
10/2011 - 03/2007
2
Estrogen Receptors
IBA
06/2010 - 01/2008
2
Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))
IBA
04/2010 - 01/2009
2
Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)
IBA
02/2008 - 01/2008
2
Antineoplastic Agents (Antineoplastics)
IBA
10/2005 - 12/2004
1
HMGB1 Protein (HMG1)
IBA
02/2024
1
Protein-Arginine N-Methyltransferases (Methyltransferase, Protein Arginine)
IBA
02/2024
1
Calreticulin
IBA
02/2024
Therapy/Procedure
78
Therapeutics
03/2024 - 10/2004
12
Drug Therapy (Chemotherapy)
01/2022 - 03/2004
10
Immunotherapy
01/2024 - 01/2018
4
Retreatment
11/2023 - 02/2019
3
Precision Medicine
01/2020 - 11/2011
2
Aftercare (After-Treatment)
01/2019 - 05/2005
1
Intravenous Administration
02/2024